NCT07033104

Brief Summary

Evaluate calcitonin as an adjuvant to bupivacaine in ultrasound guided tansversalis fascia plane block

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 13, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

June 24, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

June 24, 2025

Status Verified

May 1, 2025

Enrollment Period

4 months

First QC Date

June 13, 2025

Last Update Submit

June 23, 2025

Conditions

Transversalis Fascia Plane Block

Outcome Measures

Primary Outcomes (1)

  • time to first rescue analgesia

    24 hours

Study Arms (2)

Transversalis fascia plane block with bupivacaine

ACTIVE COMPARATOR

us guided transversalis fascia plane block with bupivacaine

Other: us guided Transversalis fascia plane block

Transversalis fascia plane block with calcitonin and bupivacaine

ACTIVE COMPARATOR

us guided transvesalis fascia plane block with calcitonin and bupivacaine

Other: us guided Transversalis fascia plane block

Interventions

us guided Transversalis fascia plane blockOTHER

addition of calcitonin to pubivacaine

Transversalis fascia plane block with bupivacaineTransversalis fascia plane block with calcitonin and bupivacaine

Eligibility Criteria

Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • female pt ASA2 scheduled for cs under spinal anesthesia

You may not qualify if:

  • patient refusal ASAmore than 3 patients with pregnancy related disease emergency cs history of coagulopathy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

tanta University hospital

Tanta, Gharbia Governorate, Egypt

RECRUITING

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
PREVENTION
Intervention Model
SEQUENTIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Marwa Abogabal

Study Record Dates

First Submitted

June 13, 2025

First Posted

June 24, 2025

Study Start

April 1, 2025

Primary Completion

August 1, 2025

Study Completion

September 1, 2025

Last Updated

June 24, 2025

Record last verified: 2025-05

Locations

EG(1)